Oppenheimer analyst Leland Gershell downgraded Crinetics (NASDAQ: CRNX) from Outperform to Perform.The analyst comments: “VRTX (OP, Olson) will acquire CRNX ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE